SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012191
Filing Date
2022-08-04
Accepted
2022-08-04 16:11:28
Documents
90
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20220630x10q.htm   iXBRL 10-Q 1975486
2 EX-31.1 irwd-20220630xex31d1.htm EX-31.1 16578
3 EX-31.2 irwd-20220630xex31d2.htm EX-31.2 16637
4 EX-32.1 irwd-20220630xex32d1.htm EX-32.1 7975
5 EX-32.2 irwd-20220630xex32d2.htm EX-32.2 7939
  Complete submission text file 0001558370-22-012191.txt   9139499

Data Files

Seq Description Document Type Size
6 EX-101.SCH irwd-20220630.xsd EX-101.SCH 64672
7 EX-101.CAL irwd-20220630_cal.xml EX-101.CAL 67536
8 EX-101.DEF irwd-20220630_def.xml EX-101.DEF 310665
9 EX-101.LAB irwd-20220630_lab.xml EX-101.LAB 495762
10 EX-101.PRE irwd-20220630_pre.xml EX-101.PRE 483816
84 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20220630x10q_htm.xml XML 1790725
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 221136666
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences